Effect of Sodium Glucose Co-transporter Type 2 Inhibitors on The Infract size among Diabetic Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Percutane

Potential Cardio-protective Role of Dapagliflozin in Post Myocardial Infarction Patients

Heart Failure with Preserved Ejection Fraction

Exploring the role of Glucagon-Like Peptide-1 in heart failure with preserved ejection fraction among patients with type 2 Diabetes Mellitus

IMPACT OF SACUBITRIL/VALSARTAN COMBINATION ON PREVALENCE OF ARRHYTHMIA IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION

Potential mechanisms underlying the renoprotective effect of empagliflozin, a novel selective sodium glucose co-transporter (SGLT) 2 inhibitor, against diabetic nephropathy in st

The early effect of dapagliflozin on diastolic function parameters in patients with mid range and reduced ejection fraction heart failure

The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction

Safety and Efficacy of Sacubitril ̸ Valsartan drug in Heart Failure Patients

Impact of Sacubitril–Valsartan Treatment on Diastolic Function and Right Ventricular Function in Patient with Heart Failure with Reduced Ejection Fraction